医疗设备研发商Healthy.io收购Labrador Health，推动家庭肾脏诊断的未来发展-动脉网

Healthy.io Acquires Labrador Health, Advancing the Future of At-Home Kidney Diagnostics

CISION 等信源发布 2025-04-29 00:57



可切换为仅中文







BOSTON

波士顿

，

April 28, 2025

2025年4月28日

/PRNewswire/ -- Healthy.io is excited to announce that it has just signed an agreement to acquire Labrador Health, a startup that has developed a breakthrough technology for quantitative home testing.

/PRNewswire/ -- Healthy.io 很高兴地宣布，刚刚签署了一项协议，收购开发了突破性定量家庭检测技术的初创公司 Labrador Health。

This strategic acquisition marks a step forward in Healthy.io's mission of transforming home-based diagnostics with lab-quality accuracy, powered by the smartphone. By integrating Labrador Health's technology with Healthy.io's FDA-cleared and CE-marked suite of products already available globally, the company is poised to launch the next generation of quantitative at-home kidney testing, expanding access to high-quality diagnostics around the world..

这项战略性收购标志着 Healthy.io 在通过智能手机实现具有实验室质量精度的家庭诊断任务上迈出了重要的一步。通过将拉布拉多健康公司的技术与 Healthy.io 已在全球推出的、经美国食品药品监督管理局（FDA）批准和欧洲合格认证（CE）的产品套件相结合，该公司准备推出下一代定量家庭肾脏检测，扩大全球获得高质量诊断的机会。

The team is already collaborating on developing the first ever quantitative, home-based ACR test - expected to launch in 2026. This home test is designed to tackle the significant global care-gap in Chronic Kidney Disease. With its novel quantitative features, the product will align with existing care-pathways and international reimbursement schemes, while making testing more accessible and routine - enabling earlier detection and better outcomes at scale..

该团队已经在合作开发首个基于家庭的定量ACR测试，预计将于2026年推出。这项家庭测试旨在解决慢性肾病在全球范围内的显著护理缺口。凭借其创新的定量功能，该产品将与现有的护理路径和国际报销机制相契合，同时使检测更加便捷和常规，从而实现更早的发现和更大规模的更好疗效。

As part of the integration, all Labrador team members will be joining Healthy.io. At the same time, the company is sharpening its focus on scalable, high-impact offerings by realigning internal resources to accelerate commercialization and innovation in its core markets. This renewed focus will support continued growth of Healthy.io's existing semi-quantitative product while driving the development of next-generation diagnostics enabled by the newly acquired technology..

作为整合的一部分，所有拉布拉多团队成员都将加入 Healthy.io。同时，公司正在通过重新调整内部资源，聚焦于可扩展、高影响力的业务，以加速其核心市场的商业化和创新进程。这一新的聚焦方向将支持 Healthy.io 现有半定量产品的持续增长，同时推动基于新收购技术的下一代诊断工具的开发。

'This acquisition is about accelerating our mission to deliver clinical-grade testing from the comfort of home,' said

“这次收购是为了加速我们从家中提供临床级检测的使命，”

Geoffrey Martin

杰弗里·马丁

, CEO of Healthy.io. 'We're excited to welcome the Labrador team and to build on our shared commitment to improving kidney care.'

，Healthy.io首席执行官。“我们很高兴欢迎Labrador团队，并共同致力于改善肾脏护理。”

'With just

‘只需

$5 million

500万美元

in funding and a small team, we achieved significant technological milestones,' said

“在资金和小团队的支持下，我们达成了重要的技术里程碑，”他表示。

Yoav Kessler

约阿夫·凯斯勒

, CEO of Labrador Health. 'We knew that partnering with Healthy.io would be the key to taking our innovation to the next level, combining our breakthrough with their scale and expertise to make a truly global impact.'

Labrador Health公司首席执行官表示：“我们知道与Healthy.io合作将是将我们的创新提升到新水平的关键，结合他们的规模和专业知识，将我们的突破性成果推向全球，产生真正的影响。”

Addressing the Growing Need for Early Kidney Disease Detection in the U.S.

满足美国对早期肾病检测日益增长的需求

Chronic Kidney Disease (CKD) affects over 35 million Americans, yet millions remain undiagnosed. Traditional testing methods often limit access and adherence, especially in at-risk communities. Healthy.io's at-home semi-quantitative tests have already proven effective in improving access and early detection.

慢性肾病（CKD）影响着超过3500万美国人，但仍有数百万人未被诊断。传统的检测方法常常限制了获取和依从性，尤其是在高风险社区。Healthy.io的居家半定量检测已经被证明在提高获取性和早期发现方面非常有效。

The addition of Labrador's quantitative technology offers even greater clinical insight and empowers better disease management..

拉布拉多定量技术的加入提供了更深入的临床见解，并增强了疾病管理能力。

A New Chapter in Home-Based Diagnostics

家庭诊断的新篇章

This combination represents a step-change in the accessibility and quality of at-home testing. By uniting Labrador's innovation with Healthy.io's computer vision technologies and operational scale, the companies are poised to redefine how kidney health is monitored and managed—bringing precise, proactive care directly into the hands of patients worldwide..

这一组合代表着家庭检测的可及性和质量迈上了一个新台阶。通过将拉布拉多公司的创新技术与健康科技公司（Healthy.io）的计算机视觉技术和运营规模相结合，这些公司准备重新定义肾脏健康的监测和管理方式——将精确、积极的护理直接交到全球患者手中。

About Healthy.io

关于Healthy.io

Healthy.io transforms smartphone cameras into clinical-grade diagnostic tools. Its solutions support at-home testing for chronic kidney disease, urinary tract infections, and wound care, reducing barriers to care and driving meaningful health outcomes. Healthy.io partners with leading health systems and retailers across the U.S.

Healthy.io 将智能手机摄像头转变为临床级诊断工具。其解决方案支持在家中进行慢性肾病、尿路感染和伤口护理的测试，减少就医障碍并推动实现有意义的健康结果。Healthy.io 与美国领先的卫生系统和零售商合作。

and .

和。

Europe

欧洲

。

About Labrador Health

关于拉布拉多健康

Labrador Health developed a cutting-edge platform for quantitative urine testing, combining proprietary biochemistry and microfluidics, and computer vision technologies to deliver lab-grade results at home. The company has partnered with leading clinical institutions to validate its solution, and its technology has received strong interest from both the clinical and investor communities.

Labrador Health 开发了一个尖端的定量尿液检测平台，结合了专有的生物化学、微流体技术和计算机视觉技术，能够在家中提供实验室级别的检测结果。该公司已与领先的临床机构合作验证其解决方案，其技术引起了临床和投资界的浓厚兴趣。

Founded in 2021 by .

成立于2021年，由。

Yoav Kessler

约阿夫·凯斯勒

, PhD, and repeat entrepreneur and investor

博士，连续创业者和投资者

Amit Avner

阿米特·阿夫纳

, Labrador has raised

，拉布拉多已经筹集了

$5 million